Collagen cross-linking effect on progressive keratoconus in patients younger than 18 years of age: A clinical trial

BACKGROUND: Keratoconus is a bilateral non-inflammatory corneal disease. Collagen cross-linking (CXL) is a new treatment option for the disease that uses ultraviolet A light irradiation and riboflavin administration. The aim of this study is to evaluate the effect of CXL on corneal topographic and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyman, Alireza, Kamali, Ali, Khushabi, Maral, Nasrollahi, Kobra, Kargar, Neda, Taghaodi, Maryam, Razmjoo, Hasan, Fazel, Farhad, Salesi, Asiyeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685639/
https://www.ncbi.nlm.nih.gov/pubmed/26693470
http://dx.doi.org/10.4103/2277-9175.170240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685639/
https://www.ncbi.nlm.nih.gov/pubmed/26693470
http://dx.doi.org/10.4103/2277-9175.170240

Ejemplares similares